Webinar on demand
TARGIT-A – confronto con altri studi APBI
27 maggio 2021
· 45 MIN VISIONE
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.100.100.0,63,591,654.file/dr-sperk-portrait-2020.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.360.360.0,63,591,654.file/dr-sperk-portrait-2020.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/dr-sperk-portrait-2020.jpg/_jcr_content/renditions/original.image_file.591.591.0,63,591,654.file/dr-sperk-portrait-2020.jpg"})
Autore
Elena Sperk, MD, PhD
Professore assistente, Medico responsabile senior e Responsabile dell’Unità di sperimentazione clinica presso il Dipartimento di radioterapia oncologica del Centro Medico Universitario di Mannheim, Mannheim, Germania
Riepilogo
La Dr.ssa Elena Sperk parla dello studio a lungo termine TARGIT-A recentemente pubblicato e confrontandolo con altri approcci APBI
Questo webinar clinico registrato inizia con approfondimenti sullo studio a lungo termine TARGIT-A recentemente pubblicato, concentrandosi sulla progettazione della sperimentazione, sulle caratteristiche dei pazienti e sui risultati clinici, nonché sugli effetti collaterali, sulla cosmesi e sugli effetti ambientali. Nella seconda parte del webinar la Dr.ssa Elena Sperk delinea un confronto interessante e puntuale con altri approcci APBI, confrontando aspetti chiave come popolazione di pazienti, risultati clinici e tecniche. Il webinar termina con una sessione di domande e risposte.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.100.56.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.360.203.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.768.432.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1024.576.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1280.720.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1440.810.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-targit-a-comparison-to-other-apbi-studies_preview.jpg/_jcr_content/renditions/original.image_file.1913.1076.0,3,1913,1080.file/627-targit-a-comparison-to-other-apbi-studies_preview.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.100.56.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.360.203.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.768.432.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1024.576.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1280.720.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.100.56.file/preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.360.203.file/preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png"})